Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/27/2025

Clasificación y Diagnóstico de Miomas Uterinos

Clasificación Anatómica Principal

  • Los miomas uterinos se clasifican principalmente según su localización anatómica en tres categorías: submucosos (SM), intramurales (IM) y subserosos (SS), siendo esta clasificación fundamental para determinar el pronóstico reproductivo y las opciones terapéuticas 1, 2, 3
  • Los miomas submucosos se localizan debajo del endometrio y protruyen hacia la cavidad uterina, causando distorsión de la misma 1, 2
  • Los miomas submucosos tienen el mayor impacto negativo en la fertilidad, con tasas de embarazo de solo 10% y tasas de implantación de 4.3% en tratamientos de reproducción asistida 1, 2
  • Los miomas submucosos se asocian con mayor riesgo de aborto espontáneo, parto prematuro, presentación anormal en el trabajo de parto, obstrucción del canal del parto, hemorragia postparto y sepsis puerperal 2, 3
  • El ultrasonido transvaginal tiene una sensibilidad del 90% y especificidad del 98% para diagnosticar miomas submucosos 4, 5, 6
  • Los miomas intramurales se localizan dentro de la pared muscular del útero (miometrio) sin protruir significativamente hacia la cavidad o la superficie serosa 1, 2
  • Los miomas intramurales reducen significativamente las tasas de embarazo (16.4%) y de implantación (6.4%) comparado con mujeres sin miomas, incluso cuando no hay distorsión de la cavidad uterina 1, 2
  • Los miomas subserosos se localizan en la superficie externa del útero, bajo la serosa peritoneal, y no afectan significativamente la fertilidad, con tasas de embarazo (34.1%) y de implantación (15.1%) similares a mujeres sin miomas (30.1% y 15.7% respectivamente) 1, 2

Métodos Diagnósticos para la Clasificación

  • La combinación de ultrasonido transabdominal (TAUS) y transvaginal (TVUS) es la modalidad más útil para la evaluación inicial de miomas sospechados 5, 6
  • El TVUS tiene una sensibilidad del 90-99% para detectar miomas uterinos 4, 5, 6
  • El ultrasonido 3D con Doppler muestra alta precisión para diferenciar miomas de adenomiosis con sensibilidad del 93%, especificidad del 96% 4, 5, 6
  • La RMN es superior al ultrasonido para identificar y mapear miomas, pudiendo alterar el manejo en hasta 28% de las pacientes 4
  • La RMN proporciona información crucial sobre localización, volumen, número, intensidad de señal en T1 y T2, y realce con contraste 4
  • La RMN con contraste de gadolinio permite evaluar la viabilidad del mioma, anatomía de las arterias uterinas y detección de suplencia colateral ovárica 4

Consideraciones Clínicas Importantes

  • Los miomas submucosos e intramurales requieren consideración de tratamiento quirúrgico o médico antes de recurrir a tecnologías de reproducción asistida 1, 2
  • Los miomas no viables o autoinfartados se encuentran en hasta 20% de las candidatas a embolización y no responden a este tratamiento, siendo importante identificarlos en la planificación terapéutica 4

Uterine Fibroids Diagnosis and Treatment

Diagnostic Imaging

  • The American College of Radiology recommends combined transabdominal and transvaginal ultrasound as the most useful initial modality for evaluating suspected uterine fibroids, with transvaginal ultrasound achieving 90-99% sensitivity for detecting fibroids overall and 90% sensitivity with 98% specificity for submucosal fibroids specifically 7, 8, 9
  • MRI is superior to ultrasound for identifying and mapping fibroids, altering management in up to 28% of patients, and provides crucial information on location, volume, number, T1/T2 signal intensity, and enhancement patterns 10
  • Gadolinium-based contrast is preferred when MRI is clinically indicated for assessing fibroid vascularity and other characteristics 7, 8, 10

Fibroid Characteristics

  • Submucosal fibroids may be amenable to hysteroscopic resection if intracavitary 10
  • Intramural fibroids are amenable to uterine fibroid embolization (UFE) when they contact the endometrium, though may be expelled following successful UFE in 2.2% to 7.7% of cases 10
  • Large subserosal or pedunculated fibroids may be better visualized with transabdominal ultrasound due to limited field-of-view on transvaginal approach 7, 8
  • The "bridging vessel sign" (interface vessels between uterus and juxtauterine masses) on color Doppler helps differentiate subserosal fibroids from extrauterine tumors 7, 10

Advanced Imaging Techniques

  • MRI signal intensity and contrast enhancement patterns allow characterization of fibroids as classic, degenerated, cellular, or atypical 7, 8, 9
  • Degenerated fibroids include hyaline degeneration, carneous (red) degeneration, hydropic degeneration, fatty degeneration, cystic degeneration, and myxoid degeneration 7, 8, 9
  • Conventional MRI cannot reliably differentiate fibroids from sarcomas; diffusion-weighted imaging with ADC values incorporated into an MRI algorithm achieves 83-88% sensitivity and 97-100% specificity for this distinction 8, 9, 10

Diagnostic Accuracy and Clinical Implications of Ultrasound‑Identified Uterine Fibroid Locations

Ultrasound Performance Metrics

  • Transvaginal ultrasound detects submucosal fibroids with approximately 90 % sensitivity and 98 % specificity, making it a highly reliable tool for confirming cavity‑distorting lesions that are most strongly associated with heavy menstrual bleeding. 11
  • When both transabdominal and transvaginal approaches are combined, overall detection of uterine fibroids reaches 90–99 % sensitivity, providing optimal visualization of fibroid burden regardless of location. 11

Typical Clinical Presentations by Fibroid Location

  • Subserosal fibroids generally produce minimal or no menstrual bleeding abnormalities and are chiefly associated with bulk‑related symptoms such as pelvic pressure, urinary frequency, or constipation. 11
  • Cervical fibroids are rare, accounting for less than 5 % of all uterine fibroids, and more commonly present with dyspareunia, urinary obstruction, or vaginal discharge rather than heavy menstrual bleeding. 11

Imaging Guidance for Management Decisions

  • Ultrasound should explicitly assess whether a fibroid distorts the endometrial cavity; confirmation of cavity distortion indicates a submucosal location and directs clinicians toward hysteroscopic resection as the preferred treatment. 11
  • Intramural fibroids that abut the endometrium can cause menorrhagia, but the bleeding is typically less severe than that produced by true submucosal lesions; precise ultrasound characterization of the degree of cavity involvement is essential to differentiate management pathways (hysteroscopic versus alternative surgical approaches). 11

REFERENCES

4

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

5

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

6

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

7

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

8

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

9

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

10

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022

11

acr appropriateness criteria® fibroids. [LINK]

Journal of the American College of Radiology, 2022